Merck
AstraZeneca and Merck obtain EMA orphan status for selumetinib
AstraZeneca and Merck (MSD) have secured the European Medicines Agency orphan designation for a MEK 1/2 inhibitor called selumetinib to…
Merck gets Chinese approval for Keytruda to treat skin cancer
Merck has secured approval from the China National Drug Administration (CNDA) for the use of its Keytruda medicine to treat…
